‘They Lied about High LDL!’ - The Corrupt Science behind Heart Disease

Summary of the video’s main arguments (LDL, familial hypercholesterolemia, and “corruption” claims)

• The cholesterol/LDL debate is presented as not fully settled, with “most scientists” arguing that LDL causally contributes to cardiovascular disease (CVD), while others dispute that interpretation.
• The episode centers on a discussion between Dr. Ken Berry and Dr. David Diamond, referencing a study Diamond cites to argue that LDL’s danger is overstated, particularly in older adults.

1) What familial hypercholesterolemia (FH) is claimed to show

FH is described as a genetic condition in which LDL receptors don’t function properly, leading to very high LDL:

• Heterozygous FH: LDL is elevated (e.g., roughly 2–3× normal).
• Homozygous FH: even higher LDL (e.g., roughly 3–4× normal), considered more severe.

Diamond’s premise (and a slide he describes) is used to argue that FH patients do not uniformly die young, countering the “doomed” interpretation often taught in medical school.

2) The core study: age-specific mortality patterns differ

A central piece of evidence discussed is a graph of age-specific mortality, interpreted as follows:

• Before ~40 years old: mortality appears only slightly above the general-population baseline and is often not statistically significant, suggesting many people with FH do not die in early decades.
• CVD-specific mortality: the video argues there is an increased risk of cardiovascular deaths roughly from age 20–70, but the data is described as underpowered/uncertain, especially for the youngest subgroups due to small sample sizes and wide uncertainty.

3) Why all-cause mortality can be misleading

A key analytical point is that relying on all-cause mortality may obscure LDL/CVD relationships because it aggregates deaths from many causes (e.g., cancer, dementia, diabetes) that may not be directly linked to LDL.

The episode argues that when focusing on cause-specific CVD mortality, the “protective LDL” interpretation becomes less supported for younger to middle ages.

4) The “older people survive better with high LDL” claim—and critique

Diamond’s prominent claim is that after about age 60–70, people with FH show lower all-cause mortality than the general population (including a reported ~40% lower mortality in older age bands).

The video counters that this does not necessarily prove LDL is harmless, citing several possible explanations:

• Survivorship bias: only the more resilient individuals (potentially those receiving better care) remain alive into older ages.
• Unmeasured confounding: the study is alleged not to have adequately adjusted for factors such as body weight, blood pressure, insulin resistance, smoking, and activity.
• Treatment timing unknown: early diagnosis could lead to earlier initiation of lipid-lowering therapy.
• Small sample size: few deaths in subgroups create wide confidence intervals, making results unstable.

The analyst concludes that while the all-cause finding may look “rosy,” it is not strong enough to overturn LDL’s role in heart-disease risk.

5) Bottom-line conclusion of the episode

The episode’s overall position is:

• FH may show little or no increase in all-cause mortality in some age ranges (especially older adults),
• but cardiovascular disease mortality remains increased for those under ~70.

The broader takeaway is that elevated apoB-containing lipoproteins (including LDL) are likely still cardiovascular risk factors, even if this risk does not always appear clearly in all-cause mortality statistics for the elderly.

Presenters / contributors mentioned

• Dr. Ken Berry
• Dr. David Diamond
• Centrifuge host/analyst narrator (not named in the subtitles)
• Red Brown (asked a question in the live/PhD community interruption)
• Brown and Goldstein (authors of earlier FH-related findings mentioned)